Deceased Organ Donation From Pediatric Donors: Does the Literature Really Help Us? Implication for More Powerful

M Mojtabaee1, F Sadegh Beigee1, F Ghorbani2

  • 1Lung Transplantation Research Center (LTRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Transplantation Proceedings
|September 20, 2017
PubMed

Insights

Pediatric organ donors under 5 years require specialized management due to unique complications like hyperglycemia and acidosis. Despite these challenges, young donors remain a valuable resource for organ procurement.

Area of Science:

  • Pediatric Organ Donation
  • Critical Care Medicine
  • Transplantation

Background:

  • Brain-dead pediatric donors are crucial for organ transplantation.
  • Donors under 5 years present unique management challenges not fully addressed in current guidelines.

Purpose of the Study:

  • To compare the clinical characteristics and suitability for organ donation in brain-dead pediatric donors under 5 years versus those aged 5-12 years.
  • To identify specific management needs for younger pediatric organ donors.

Main Methods:

  • Retrospective analysis of 79 brain-dead pediatric donors.
  • Donors categorized into two groups: under 5 years (Group A) and 5-12 years (Group B).
  • Comparison of metabolic, hemodynamic, hematologic, and electrolyte status, and organ suitability.

Main Results:

  • Younger donors (Group A) showed higher rates of hyperglycemia and respiratory acidosis.
  • Older donors (Group B) had increased prevalence of anemia and coagulopathy.
  • Group A required more high-dose inotropic support, yet organ yield was comparable between groups.

Conclusions:

  • Donors under 5 years necessitate tailored management strategies due to distinct physiological complications.
  • Despite management complexities, pediatric donors under 5 years represent a significant and valuable source for organ procurement.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
552
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
512
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.7K